{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:00:45Z","timestamp":1777622445071,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.expneurol.2010.07.003","type":"journal-article","created":{"date-parts":[[2010,7,19]],"date-time":"2010-07-19T07:09:04Z","timestamp":1279523344000},"page":"320-327","source":"Crossref","is-referenced-by-count":11,"title":["In vivo adsorption of autoantibodies in myasthenia gravis using Nanodisc-incorporated acetylcholine receptor"],"prefix":"10.1016","volume":"225","author":[{"given":"Jian Rong","family":"Sheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Grimme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palash","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.B.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Artinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bellur S.","family":"Prabahakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew N.","family":"Meriggioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2010.07.003_bb0005","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1110\/ps.03267503","article-title":"Self-assembly of single integral membrane proteins into soluble nanoscale phospholipid bilayers","volume":"12","author":"Bayburt","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.abb.2006.03.013","article-title":"Assembly of single bacteriorhodopsin trimers in bilayer Nanodiscs","volume":"450","author":"Bayburt","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0015","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1074\/jbc.M701433200","article-title":"Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins","volume":"282","author":"Bayburt","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1084\/jem.151.1.204","article-title":"Experimental myasthenia gravis: a murine system","volume":"151","author":"Berman","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/JVI.01355-09","article-title":"Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection","volume":"84","author":"Bhattacharya","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1189\/jlb.70.6.849","article-title":"Modes of action of Freund's adjuvants in experimental models of autoimmune diseases","volume":"70","author":"Billiau","year":"2001","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0035","doi-asserted-by":"crossref","first-page":"11509","DOI":"10.1073\/pnas.0604988103","article-title":"Nanodiscs separate chemoreceptor oligomeric states and reveal their signaling properties","volume":"103","author":"Boldog","year":"2006","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0076-6879(07)23014-9","article-title":"Using Nanodiscs to create water-soluble transmembrane chemoreceptors inserted in lipid bilayers","volume":"423","author":"Boldog","year":"2007","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0045","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1515\/BC.2009.091","article-title":"The Nanodisc: a novel tool for membrane protein studies","volume":"390","author":"Borch","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1526-0968.2000.004004291.x","article-title":"The six year experience of plasmapheresis in patients with myasthenia gravis","volume":"4","author":"Chiu","year":"2000","journal-title":"Ther. Apher."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0060","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM197711242972102","article-title":"Plasmaphereses and immunosuppressive drug therapy in myasthenia gravis","volume":"297","author":"Dau","year":"1977","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0065","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/ja0393574","article-title":"Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size","volume":"126","author":"Denisov","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0070","first-page":"267","article-title":"Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations","volume":"52","author":"Engel","year":"1977","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.copbio.2007.11.008","article-title":"Nanotoxicity: the growing need for in vivo study","volume":"18","author":"Fischer","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high dose intravenous immunoglobulin in myasthenia gravis Myasthenia Gravis Clinical Study Group","volume":"41","author":"Gajdos","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0085","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/cimm.1993.1198","article-title":"Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis","volume":"150","author":"Gregorian","year":"1993","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.45.2.338","article-title":"Treatment of myasthenia gravis by immunoadsorption of plasma","volume":"45","author":"Grob","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2010.07.003_bb0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2005.04.013","article-title":"Preparation of an immunoadsorbent coupled with a recombinant antigen to remove anti-acetylcholine receptor antibodies in abnormal serum","volume":"303","author":"Guo","year":"2005","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02786398","article-title":"Myasthenia gravis as a prototype autoimmune receptor disease","volume":"16","author":"Hoedemaekers","year":"1997","journal-title":"Immunol. Res."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI200316039","article-title":"Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis","volume":"112","author":"Jambou","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0110","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2144\/000112169","article-title":"Functional reconstitution of Beta2-adrenergic receptors utilizing self-assembling Nanodisc technology","volume":"40","author":"Leitz","year":"2006","journal-title":"Biotechniques"},{"key":"10.1016\/j.expneurol.2010.07.003_bb0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O","article-title":"Acetylcholine receptors and myasthenia","volume":"23","author":"Lindstrom","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2010.07.003_bb0120","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1523\/JNEUROSCI.2833-09.2009","article-title":"Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity","volume":"29","author":"Luo","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0130","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1021\/bi602371n","article-title":"Application of phospholipid bilayer Nanodiscs in the study of membranes and membrane proteins","volume":"46","author":"Nath","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2010.07.003_bb0135","series-title":"Concepts in viral pathogenesis","first-page":"210","article-title":"Virus-induced autoimmunity","author":"Notkins","year":"1984"},{"key":"10.1016\/j.expneurol.2010.07.003_bb0210","doi-asserted-by":"crossref","first-page":"26980","DOI":"10.1074\/jbc.M110731200","article-title":"Expression of soluble ligand- and antibody-binding extracellular domain of human acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding","volume":"277","author":"Psaridi-Linardki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","article-title":"Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor \u03b1-subunit","volume":"159","author":"Psaridi-Linardki","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.transci.2004.07.014","article-title":"Imunoadsorption therapy and complement activation","volume":"32","author":"Ptak","year":"2005","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0150","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005072-197803000-00008","article-title":"Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis","volume":"37","author":"Sahashi","year":"1978","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0155","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1749-6632.1987.tb51326.x","article-title":"Plasmapheresis in myasthenia gravis","volume":"505","author":"Seybold","year":"1987","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0160","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.4049\/jimmunol.177.8.5296","article-title":"Suppression of experimental autoimmune myasthenia gravis (EAMG) by Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) is associated with an expansion of FoxP3+ regulatory T cells","volume":"177","author":"Sheng","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clim.2008.03.509","article-title":"Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia","volume":"128","author":"Sheng","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0170","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/intimm\/9.5.679","article-title":"Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines","volume":"9","author":"Tang","year":"1997","journal-title":"Int. Immunol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0175","doi-asserted-by":"crossref","first-page":"R762","DOI":"10.1152\/ajpregu.00270.2003","article-title":"Histological assessment of intermediate and long-term creatine monohydrate supplementation in mice and rats","volume":"285","author":"Tarnopolsky","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0180","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1242\/jeb.01204","article-title":"Phylogenetic conservation of disulfide-linked, dimeric acetylcholine receptor pentamers in southern ocean electric rays","volume":"207","author":"Tierney","year":"2004","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0185","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00605.x","article-title":"Immunology of disorders of neuromuscular transmission","volume":"183","author":"Vincent","year":"2006","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.expneurol.2010.07.003_bb0195","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.07.003_bb0200","doi-asserted-by":"crossref","first-page":"27575","DOI":"10.1074\/jbc.271.44.27575","article-title":"Assembly of the nicotinic acetylcholine receptor","volume":"271","author":"Wang","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"Unit 15","key":"10.1016\/j.expneurol.2010.07.003_bb0205","first-page":"8","article-title":"Experimental autoimmune myasthenia gravis in the mouse","volume":"15","author":"Wu","year":"2001","journal-title":"Curr. Protoc. Immunol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610002414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610002414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T05:27:54Z","timestamp":1685683674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488610002414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0014488610002414"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.07.003","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}